Understanding Toxoplasmosis in the United States Through "Large Data" Analyses.

ABSTRACT:

Background

Toxoplasma gondii infection causes substantial morbidity and mortality in the United States, and infects approximately one-third of persons globally. Clinical manifestations vary. Seropositivity is associated with neurologic diseases and malignancies. There are few objective data concerning US incidence and distribution of toxoplasmosis.

Methods

Truven Health MarketScan Database and International Classification of Diseases, Ninth Revision (ICD-9) codes, including treatment specific to toxoplasmosis, identified patients with this disease. Spatiotemporal distribution and patterns of disease manifestation were analyzed. Comorbidities between patients and matched controls were compared.

Results

Between 2003 and 2012, 9260 patients had ICD-9 codes for toxoplasmo

SUBMITTER: Lykins J 

PROVIDER: S-EPMC4967610 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature